Keryx’s Perifosine Gets Second Orphan Drug Status

Published July 16, 2010

Keryx’s perifosine gets second orphan drug status
Keryx Biopharmaceuticals Inc. said Wednesday that its experimental cancer drug perifosine received orphan drug status as a treatment for neuroblastoma, a cancer that affects the nervous system and mostly strikes young…
Read more on Channel 8 San Diego

East Texas doctor, pharmacist weigh in on diabetes drug, Avandia
It is a drug that has been a lightning rod for controversy, after a report linked it to increased risk of heart attacks. But in a split decision, the FDA announced the diabetes drug Avandia will remain on the market.
Read more on KLTV 7 Tyler